The CDIATM Ketamine Colloidal Gold Test Cassette (Urine) is a lateral flow chromatographic immunoassay for the detection of ketamine and its metabolites in human urine.
Ketamine antigen is coated on the test region of the nitrocellulose membrane of the strips, and ketamine antibody is labeled with colloid gold. During a test, the colloid gold labeled antibody coated in the strip move forward along the membrane, and a red line will show up when the antibody gathers with the antigen in the test line; if ketamine in the sample is over the detection limit, line T is blank; on the other wise, if ketamine in the sample is less than the detection limit, line T is red.
Ketamine is a drug used in human and veterinary medicine. Ketamine has a wide range of effects in humans, including analgesia, anesthesia, hallucinations and elevated blood pressure. Ketamine is primarily used for the induction and maintenance of general anesthesia, usually in combination with a sedative. The common way to abuse ketamine is smoking, inhalants, intravenous injection or drink. Ketamine is metabolized mostly into metabolites and only 5% of the prototype. The drug is metabolized quickly in the body, and usually can be detected within 2-3 hours after smoking. The CDIATM Ketamine Colloidal Gold Test Cassette (Urine) is a rapid urine-screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of ketamine in urine. The CDIATM Ketamine Colloidal Gold Test Cassette (Urine) yields a positive result when the ketamine in urine exceeds 3000/2000/1000/100 ng/mL.